Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

'Intended Use' Rule: US FDA May Toss Its 'Totality Of Evidence' Standard

Jan 14 2018

• By Brenda Sandburg

FDAEntrance_1200x675

Related Content

US FDA Clarifies ‘Intended Use’ Policy For Approved Products

Jan 17 2017

‘Intended Use’ Rule: Industry Urges US FDA To Revoke ‘Totality Of Evidence’ Standard

Feb 13 2017

FDA Off-Label Reg Changes For Drugs Could Be Driven By Tobacco Policy

Oct 07 2015

Additional Topics

United States Advertising, Marketing & Sales Legal Issues Regulation FDA BioPharmaceutical

More from Marketing & Advertising

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window